Cargando…
Inhaled Corticosteroids Selectively Alter the Microbiome and Host Transcriptome in the Small Airways of Patients with Chronic Obstructive Pulmonary Disease
Background: Patients with chronic obstructive pulmonary disease (COPD) are commonly treated with inhaled corticosteroid/long-acting ß2-agonist combination therapy. While previous studies have investigated the host–microbiome interactions in COPD, the effects of specific steroid formulations on this...
Autores principales: | Yip, William, Li, Xuan, Koelwyn, Graeme J., Milne, Stephen, Leitao Filho, Fernando Sergio, Yang, Chen Xi, Hernández Cordero, Ana I., Yang, Julia, Yang, Cheng Wei Tony, Shaipanich, Tawimas, van Eeden, Stephan F., Leung, Janice M., Lam, Stephen, McNagny, Kelly M., Sin, Don D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138653/ https://www.ncbi.nlm.nih.gov/pubmed/35625847 http://dx.doi.org/10.3390/biomedicines10051110 |
Ejemplares similares
-
Inhaled corticosteroids downregulate SARS-CoV-2-related genes in COPD: results from a randomised controlled trial
por: Milne, Stephen, et al.
Publicado: (2021) -
Airway Eosinophilia on Bronchoalveolar Lavage and the Risk of Exacerbations in COPD
por: Ho, Chunman Germain, et al.
Publicado: (2022) -
Systemic and Airway Epigenetic Disruptions Are Associated with Health Status in COPD
por: Hernandez Cordero, Ana I., et al.
Publicado: (2023) -
Macrophages with reduced expressions of classical M1 and M2 surface markers in human bronchoalveolar lavage fluid exhibit pro-inflammatory gene signatures
por: Takiguchi, Hiroto, et al.
Publicado: (2021) -
ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19
por: Leung, Janice M., et al.
Publicado: (2020)